- Home
- Search Results
Search Results
Filter :
FILTER BY keyword:
FILTER BY date:
FILTER BY language:
FILTER BY content type:
FILTER BY publication:
FILTER BY affiliation:
- Cincinnati Cancer Advisors, Cincinnati, OH, United States [1]
- College of Medicine, Alfaisal University, Riyadh, Saudi Arabia*Correspondence: Wasif Ali Khan [email protected] [1]
- College of Public Health and Health Informatics, King Saud bin Abdul-Aziz University, Riyadh, Saudi Arabia [1]
- Department of Basic Medical Sciences, College of Medicine, Almaarefa University, Riyadh, Saudi Arabia [1]
- Department of Clinical Medical Sciences, College of Medicine, Al Maarefa University, Riyadh, Saudi Arabia [1]
- Specialty business at GSK, Riyadh, Saudi Arabia [1]
FILTER BY article type:
FILTER BY access type:
Predictors of thyroid cancer survival in Saudi Arabia: A retrospective 10-year analysis
Background: Thyroid cancer (TC) is becoming more prevalent in Saudi Arabia currently ranking among the top three cancers affecting women. Despite its rising prevalence there has been limited assessment of the factors influencing the survival rate (SR) among the Saudi population over an extended period. Therefore this study aims to address this critical gap in knowledge by identifying the factors affecting the SR of TC comparing the SR with previous studies and exploring potential areas for improving the SR of patients.
Methods: A retrospective study analyzed secondary data from patients diagnosed with TC as recorded in the King Abdulaziz Medical City Cancer Registry in Riyadh Saudi Arabia over 10 years from 2009 to 2018.
Results: Of the total 665 TC cases the mean age at diagnosis was 46.2 years (±SD 16) and most patients were women (78.5%) with the majority being under 50 years old. The most common type of cancer was papillary thyroid carcinoma comprising 88.6% of all TCs. Over half of the cases were localized to one of the lobes of the thyroid gland with almost equal frequency between the two lobes. The 5-year SR of localized papillary thyroid carcinoma reached 96.5% in contrast to the extremely low SR of anaplastic thyroid carcinoma where most patients died within a few months of the diagnosis. Factors such as morphology tumor extension male gender and age at diagnosis significantly impacted patient survival as analyzed by the Kaplan–Meier test (p < 0.001). Compared to other types of cancer those with anaplastic thyroid carcinoma had a lower SR.
Conclusion: The SR of TC patients is predicted by factors such as their age morphological type and the presence of distant metastasis.